Kairos Pharma Ltd. (KAPA)
1.73
-0.08
(-4.42%)
USD |
NYAM |
Sep 18, 16:00
1.75
+0.02
(+1.16%)
After-Hours: 20:00
Kairos Pharma Market Cap : 5.295M for Sept. 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 5.295M |
| September 17, 2026 | 5.540M |
| September 16, 2026 | 5.540M |
| September 15, 2026 | 5.662M |
| September 14, 2026 | 5.631M |
| September 11, 2026 | 5.380M |
| September 10, 2026 | 5.142M |
| September 09, 2026 | 5.080M |
| September 08, 2026 | 5.417M |
| September 04, 2026 | 5.631M |
| September 03, 2026 | 5.111M |
| September 02, 2026 | 4.836M |
| September 01, 2026 | 5.050M |
| August 31, 2026 | 5.142M |
| August 28, 2026 | 5.080M |
| August 27, 2026 | 5.163M |
| August 26, 2026 | 38.99M |
| August 25, 2026 | 37.22M |
| August 24, 2026 | 34.79M |
| August 21, 2026 | 43.49M |
| August 20, 2026 | 44.25M |
| August 19, 2026 | 46.43M |
| August 18, 2026 | 46.52M |
| August 17, 2026 | 48.66M |
| August 14, 2026 | 51.14M |
| Date | Value |
|---|---|
| August 13, 2026 | 53.99M |
| August 12, 2026 | 53.18M |
| August 11, 2026 | 54.50M |
| August 10, 2026 | 52.49M |
| August 07, 2026 | 57.89M |
| August 06, 2026 | 58.49M |
| August 05, 2026 | 49.49M |
| August 04, 2026 | 48.77M |
| August 03, 2026 | 46.49M |
| July 31, 2026 | 45.90M |
| July 30, 2026 | 44.97M |
| July 29, 2026 | 44.84M |
| July 28, 2026 | 46.19M |
| July 27, 2026 | 46.46M |
| July 24, 2026 | 42.74M |
| July 23, 2026 | 44.67M |
| July 22, 2026 | 46.89M |
| July 21, 2026 | 53.69M |
| July 20, 2026 | 48.26M |
| July 17, 2026 | 46.49M |
| July 16, 2026 | 50.97M |
| July 15, 2026 | 47.69M |
| July 14, 2026 | 50.99M |
| July 13, 2026 | 50.67M |
| July 10, 2026 | 52.89M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.697B |
| Alnylam Pharmaceuticals, Inc. | 32.04B |
| Anika Therapeutics, Inc. | 278.50M |
| Savara, Inc. | 1.103B |
| Vericel Corp. | 2.048B |
Market Cap Related Metrics
| Price to Book Value | 1.263 |
| Price | 1.73 |
| Earnings Yield | -112.6% |